生物外科市場規模、佔有率和成長分析（按產品、應用、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，生物外科市場規模將達到 166.3 億美元，到 2025 年將達到 177.8 億美元，到 2033 年將達到 303.2 億美元，在預測期（2026-2033 年）內，複合年成長率為 6.9%。

由於政府和私營部門投資增加，以及醫療設備領域研發投入不斷成長，全球生物外科市場預計將顯著成長。關鍵成長要素包括慢性病激增、擇期手術需求上升以及醫療基礎設施的大量投資。人口老化和嚴重創傷發生率上升也顯著推動了市場擴張。越來越多的醫療保健公司生產創新生物外科產品，進一步鞏固了這一成長勢頭。手術量的增加和運動相關傷害的增加進一步推動了對生物外科解決方案的需求，而醫療設備和製藥業持續的研發投入則為市場發展創造了充滿希望的機會。總而言之，這些因素共同作用，增強了生物外科市場的發展前景。

生物外科市場促進因素

全球生物外科市場正經歷顯著成長，其主要驅動力是糖尿病、肥胖和心臟病等慢性疾病的日益增加。這些健康問題通常需要手術干預，因此對能夠促進癒合、提高手術成功率的創新生物外科解決方案的需求不斷成長。隨著醫療機構尋求能夠幫助患者康復並最佳化手術技術的先進產品，生物外科產品市場持續擴張。科技的不斷進步以及對透過有效手術介入改善患者照護的日益重視，進一步推動了這項需求。

生物外科市場限制因素

生物外科市場面臨的主要挑戰之一是缺乏對最新技術和產品的認知和培訓。許多醫療專業人員並不完全了解先進生物外科技術的益處和應用，這可能導致這些技術未能充分利用。這種教育差距有可能阻礙創新方法的採用，並最終抑制外科手術實踐的改進。如果缺乏足夠的知識和培訓，這些先進生物外科技術的潛力可能無法充分發揮，從而阻礙市場成長和外科技術的整體發展，最終影響患者的福祉。

生物外科市場趨勢

全球生物外科市場的一大趨勢是微創手術技術的日益普及。這項轉變得益於外科技術和設備的進步，這些進步能夠改善患者的治療效果並縮短復原時間。隨著醫療機構將患者安全和舒適度置於首位，生物聚合物、止血劑和密封劑等生物外科產品因其在創傷治療和組織修復方面的有效性而備受關注。此外，慢性疾病的增加以及對先進外科手術介入的需求，也推動了生物外科領域的研究和創新，重點在於整合生物材料以提高手術療效。

目錄

介紹

• 調查目標
• 定義
• 市場覆蓋範圍

調查方法

• 資訊收集
• 二手和一手資料資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

前景
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 抑制因素
  • 任務
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 監管分析
• 供應鏈分析

生物外科市場產品分類

• 骨移植替代物
  • 去礦骨基質
  • 合成骨移植材料
  • 骨形成蛋白
  • 其他骨移植替代物
• 軟組織固定裝置
  • 合成網
  • 生物網膜
  • 同種異體移植
  • 異質骨移植
• 止血劑
  • 基於凝血酶的止血劑
  • 氧化再生纖維素止血劑
  • 複方止血劑
• 外科密封劑和黏合劑
  • 天然/生物來源密封劑和黏合劑
  • 按類型
  • 纖維蛋白基密封劑和黏合劑
  • 膠原蛋白基密封劑和黏合劑
  • 明膠基密封劑和黏合劑
  • 蛋白基密封劑
  • 其他天然/生物來源密封劑和黏合劑
  • 按原料
  • 動物源性密封劑和黏合劑
  • 人血衍生密封劑和黏合劑
  • 合成和半合成密封劑和黏合劑
  • 基於聚乙二醇水凝膠的密封劑和黏合劑
  • 氰基丙烯酸酯密封劑和黏合劑
  • 胺甲酸乙酯密封劑和黏合劑
  • 其他合成和半合成密封劑和黏合劑
• 防沾黏劑
  • 合成抗黏附劑
  • 玻尿酸抗沾黏劑
  • 再生纖維素基防黏劑
  • 聚乙二醇（PEG）防沾劑
  • 其他合成抗黏附劑
  • 天然防沾劑
  • 膠原蛋白和蛋白質黏附抑制劑
  • 纖維蛋白基抗黏連劑
• 釘線加固

生物外科市場按應用領域分類

• 整形外科手術
• 一般外科
• 神經外科
• 心血管外科
• 重組手術
• 婦科手術
• 泌尿系統
• 胸腔外科
• 其他用途

生物外科市場（按最終用戶分類）

• 醫院
• 診所
• 其他最終用戶

按地區分類的生物外科市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市佔率（2025 年）

主要企業簡介

• Baxter International Inc.（US）
• B. Braun Melsungen AG（Germany）
• Becton, Dickinson & Company（US）
• Johnson & Johnson（US）
• Medtronic Plc（Ireland）
• Integra Lifesciences Holdings Corporation（US）
• Commonwealth Serum Laboratories Limited（Australia）
• Hemostasis LLC（US）
• Pfizer Inc.（US）
• Stryker Corporation（US）
• Zimmer Biomet（US）
• Kuros Biosciences AG（Switzerland）
• Orthofix Medical Inc.（US）
• Smith & Nephew Plc（UK）
• Tissue Regenix Group Plc（UK）
• Betatech Medical（Turkey）
• Meril Life Sciences Pvt. Ltd.（India）
• Samyang Holdings Corporation（South Korea）
• Aroa Biosurgery Ltd.（New Zealand）
• Meyer-Haake Gmbh（Germany）
• Biom Up（France）
• Biocer Entwicklungs-Gmbh（Germany）
• Hannox International Corp.（Taiwan）

Biosurgery Market size was valued at USD 16.63 Billion in 2024 and is poised to grow from USD 17.78 Billion in 2025 to USD 30.32 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global biosurgery market is poised for substantial growth due to increased investments from governmental and private sectors in the medical device arena, coupled with rising R&D expenditures. Key drivers include the surging prevalence of chronic diseases, heightened demand for elective surgeries, and substantial funding for healthcare infrastructure. The aging population and the rising incidence of severe traumatic injuries also contribute significantly to market expansion. The growing number of medical firms manufacturing innovative biosurgery products further supports this growth trajectory. Increased surgical procedures and sports-related injuries are further propelling the demand for biosurgery solutions, while ongoing R&D efforts within the medical device and pharmaceutical industries create promising opportunities for market evolution. Overall, these factors collectively enhance the biosurgery landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biosurgery Market Segments Analysis

Global Biosurgery Market is segmented by Product, Application, End User, end user and region. Based on Product, the market is segmented into Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants & Adhesives, Adhesion Barriers, Staple-Line and Reinforcement Agents. Based on Application, the market is segmented into Orthopedic Surgery, General Surgery,Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Urological Surgery, Thoracic Surgery, and Other Applications. Based on End User, the market is segmented into Hospitals, Clinics, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Biosurgery Market

The global biosurgery market is experiencing significant growth driven by the rising prevalence of chronic diseases such as diabetes, obesity, and heart conditions. These health issues frequently necessitate surgical interventions, leading to an increased demand for innovative biosurgical solutions that promote healing and enhance the likelihood of successful surgical outcomes. As healthcare providers seek advanced products that can support patient recovery and optimize surgical techniques, the market for biosurgery items continues to expand. This demand is fueled by ongoing advancements in technology and an emphasis on improving patient care through effective surgical interventions.

Restraints in the Biosurgery Market

One of the significant challenges facing the biosurgery market is the limited awareness and training surrounding the latest techniques and products. Many healthcare professionals may not fully recognize the benefits and applications of advanced biosurgical methods, resulting in their underutilization. This educational gap can impede the adoption of innovative approaches, ultimately stalling progress in the enhancement of surgical practices. Without sufficient knowledge and training, the potential of these advanced biosurgical options may remain unexploited, thereby curtailing market growth and the overall evolution of surgical techniques that could benefit patients.

Market Trends of the Biosurgery Market

A significant market trend in the global biosurgery market is the increasing adoption of minimally invasive surgical procedures. This shift is driven by advancements in surgical techniques and technologies, which enhance patient outcomes and reduce recovery times. As healthcare providers prioritize patient safety and comfort, biosurgery products-such as biopolymers, hemostatic agents, and sealants-are gaining traction for their efficacy in wound healing and tissue repair. Additionally, the growing prevalence of chronic diseases and the need for advanced surgical interventions are propelling research and innovation in biosurgery, with a focus on integrating biological materials to improve surgical efficacy.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Analysis
• Supply Chain Analysis

Biosurgery Market by Product

• Market Overview
• Bone-Graft Substitutes
  • Demineralized Bone Matrix
  • Synthetic Bone Grafts
  • Bone Morphogenetic Proteins
  • Other Bone-Graft Substitutes
• Soft-Tissue Attachments
  • Synthetic Meshes
  • Biological Meshes
  • Allografts
  • Xenografts
• Hemostatic Agents
  • Thrombin-Based Hemostatic Agents
  • Oxidized Regenerated Cellulose-Based Hemostatic Agents
  • Combination Hemostatic Agents
• Surgical Sealants & Adhesives
  • Natural/Biological Sealants & Adhesives
  • By Type
  • Fibrin-Based Sealants & Adhesives
  • Collagen-Based Sealants & Adhesives
  • Gelatin-Based Sealants & Adhesives
  • Albumin-Based Sealants
  • Other Natural/Biological Sealants & Adhesives
  • By Origin
  • Animal-Based Sealants & Adhesives
  • Human Blood-Based Sealants & Adhesives
  • Synthetic And Semi-Synthetic Sealants & Adhesives
  • PEG Hydrogel-Based Sealants & Adhesives
  • Cyanoacrylate-Based Sealants & Adhesives
  • Urethane-Based Sealants & Adhesives
  • Other Synthetic and Semi-Synthetic Sealants & Adhesives
• Adhesion Barriers
  • Synthetic Adhesion Barriers
  • Hyaluronic Acid-Based Adhesion Barriers
  • Regenerated Cellulose-Based Adhesion Barriers
  • PEG-Based Adhesion Barriers
  • Other Synthetic Adhesion Barriers
  • Natural Adhesion Barriers
  • Collagen And Protein Adhesion Barriers
  • Fibrin-Based Adhesion Barriers
• Staple-Line Reinforcement Agents

Biosurgery Market by Application

• Market Overview
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Urological Surgery
• Thoracic Surgery
• Other Applications

Biosurgery Market by End User

• Market Overview
• Hospitals
• Clinics
• Other End Users

Biosurgery Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Baxter International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson & Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra Lifesciences Holdings Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Commonwealth Serum Laboratories Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemostasis LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissue Regenix Group Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Betatech Medical (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samyang Holdings Corporation (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aroa Biosurgery Ltd. (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meyer-Haake Gmbh (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biom Up (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocer Entwicklungs-Gmbh (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hannox International Corp. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments